User login
San Francisco – Treat-to-target should be the goal of every office visit for rheumatoid arthritis, according to a joint European and North American investigation involving more than 500 patients.
That’s because it works, explained study investigator Dr. Sofia Ramiro, a rheumatology fellow at Leiden (the Netherlands) University Medical Center.
The study confirms what has long been suspected but not exactly demonstrated before in a robust, real-world setting, she noted. The findings also suggest that some rheumatoid arthritis patients probably could be pushed harder toward remission.
In an interview at the annual meeting of the American College of Rheumatology, Dr. Ramiro explained the project and why it matters for clinical care.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
San Francisco – Treat-to-target should be the goal of every office visit for rheumatoid arthritis, according to a joint European and North American investigation involving more than 500 patients.
That’s because it works, explained study investigator Dr. Sofia Ramiro, a rheumatology fellow at Leiden (the Netherlands) University Medical Center.
The study confirms what has long been suspected but not exactly demonstrated before in a robust, real-world setting, she noted. The findings also suggest that some rheumatoid arthritis patients probably could be pushed harder toward remission.
In an interview at the annual meeting of the American College of Rheumatology, Dr. Ramiro explained the project and why it matters for clinical care.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
San Francisco – Treat-to-target should be the goal of every office visit for rheumatoid arthritis, according to a joint European and North American investigation involving more than 500 patients.
That’s because it works, explained study investigator Dr. Sofia Ramiro, a rheumatology fellow at Leiden (the Netherlands) University Medical Center.
The study confirms what has long been suspected but not exactly demonstrated before in a robust, real-world setting, she noted. The findings also suggest that some rheumatoid arthritis patients probably could be pushed harder toward remission.
In an interview at the annual meeting of the American College of Rheumatology, Dr. Ramiro explained the project and why it matters for clinical care.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
AT THE ACR ANNUAL MEETING
